JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
CALL
UnitedHealth
UNH
$334B
| $2.35M | ﹤0.01% |
+11,000
| New | +$2.51M |
2018 Q1
0 quarters
|
|
|
3002
PUT
UnitedHealth
UNH
$334B
| $2.35M | ﹤0.01% |
11,000
-88,000
| -89% | -$20.1M |
2014 Q3
14 quarters
|
|
|
GOOD
3003
Gladstone Commercial Corp
GOOD
$627M
| $2.35M | ﹤0.01% |
135,553
-12,619
| -9% | -$232K |
2013 Q3
18 quarters
|
|
|
RSPP
3004
PUT
DELISTED
RSP Permian, Inc.
RSPP
| $2.34M | ﹤0.01% |
+50,000
| New | +$1.97M |
2018 Q1
0 quarters
|
|
3005
CALL
Cencora
COR
$59B
| $2.34M | ﹤0.01% |
+27,100
| New | +$2.6M |
2018 Q1
0 quarters
|
|
3006
VEON
VEON
$5.21B
| $2.33M | ﹤0.01% |
35,260
+1,069
| +3% | +$89.6K |
2013 Q2
19 quarters
|
|
3007
Atlanta Braves Holdings Series A
BATRA
$3.7B
| $2.33M | ﹤0.01% |
102,362
+38,515
| +60% | +$892K |
2016 Q2
7 quarters
|
|
|
SGI
3008
Somnigroup International
SGI
$14.3B
| $2.32M | ﹤0.01% |
204,700
-723,728
| -78% | -$9.94M |
2013 Q2
19 quarters
|
|
3009
First Business Financial Services
FBIZ
$593M
| $2.32M | ﹤0.01% |
92,034
-7,441
| -7% | -$179K |
2014 Q2
15 quarters
|
|
|
CUB
3010
DELISTED
Cubic Corporation
CUB
| $2.31M | ﹤0.01% |
36,395
+14,840
| +69% | +$904K |
2014 Q4
13 quarters
|
|
|
RARX
3011
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.31M | ﹤0.01% |
436,091
+162,714
| +60% | +$1.16M |
2016 Q4
5 quarters
|
|
3012
Insteel Industries
IIIN
$571M
| $2.31M | ﹤0.01% |
83,635
+26,418
| +46% | +$787K |
2016 Q4
5 quarters
|
|
3013
Celldex Therapeutics
CLDX
$2.49B
| $2.31M | ﹤0.01% |
66,079
+64,187
| +3,393% | +$2.49M |
2017 Q4
1 quarter
|
|
3014
Sensata Technologies
ST
$6.33B
| $2.31M | ﹤0.01% |
44,580
+41,082
| +1,174% | +$2.19M |
2013 Q2
19 quarters
|
|
3015
Perdoceo Education
PRDO
$2B
| $2.3M | ﹤0.01% |
175,219
+22,389
| +15% | +$287K |
2015 Q4
9 quarters
|
|
3016
iShares US Home Construction ETF
ITB
$2.34B
| $2.3M | ﹤0.01% |
58,166
-9,310
| -14% | -$388K |
2013 Q2
19 quarters
|
|
3017
Viridian Therapeutics
VRDN
$2.2B
| $2.3M | ﹤0.01% |
21,840
-63
| -0.3% | -$6.84K |
2017 Q3
2 quarters
|
|
|
ENDP
3018
DELISTED
Endo International plc
ENDP
| $2.3M | ﹤0.01% |
386,621
-232,182
| -38% | -$1.62M |
2013 Q2
19 quarters
|
|
3019
United Bankshares
UBSI
$6.4B
| $2.29M | ﹤0.01% |
65,033
-104,526
| -62% | -$3.78M |
2014 Q4
13 quarters
|
|
|
CRHM
3020
DELISTED
CRH Medical Corporation
CRHM
| $2.29M | ﹤0.01% |
899,700
+161,800
| +22% | +$454K |
2017 Q2
3 quarters
|
|
|
FFWM
3021
DELISTED
First Foundation Inc
FFWM
| $2.29M | ﹤0.01% |
123,685
+8,467
| +7% | +$159K |
2016 Q4
5 quarters
|
|
3022
Fox Factory Holding Corp
FOXF
$783M
| $2.29M | ﹤0.01% |
65,686
-22,684
| -26% | -$861K |
2017 Q2
3 quarters
|
|
3023
Fidelity International High Dividend ETF
FIDI
$378M
| $2.29M | ﹤0.01% |
+100,000
| New | +$2.37M |
2018 Q1
0 quarters
|
|
3024
Forward Air
FWRD
$537M
| $2.28M | ﹤0.01% |
43,206
-18,760
| -30% | -$1.07M |
2013 Q2
19 quarters
|
|
3025
FormFactor
FORM
$11.7B
| $2.28M | ﹤0.01% |
167,091
+143,291
| +602% | +$2.07M |
2017 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.